Troglitazone (Rezulin, Resulin, Romozin, Noscal) is an antidiabetic and anti-
inflammatory drug, and a member of the drug class of the thiazolidinediones.
Learn about the prescription medication Rezulin (Troglitazone (removed from the
US market 3/21/00)), drug uses, dosage, side effects, drug interactions, ...
Troglitazone is an oral antihyperglycemic agent which acts primarily by
decreasing insulin resistance. Troglitazone is used in the management of type II
Jun 13, 2005 ... Troglitazone is not chemically or functionally related to either the sulfonylureas,
the biguanides, or the g-glucosidase inhibitors. Troglitazone ...
View and buy high purity Troglitazone from Tocris Bioscience, the leading
worldwide supplier of high performance life science reagents.
FDA Endocrine and Metabolic Drugs Advisory Committee Meeting on
Troglitazone. The last time I appeared before this advisory committee to present ...
Aug 14, 2013 ... Rezulin (troglitazone). Parke-Davis/Warner Lambert agree to FDA's request to
withdraw Rezulin from the market. FDA asked ...
EDITORIALS. Insight Into Hepatotoxicity: The Troglitazone. Experience. See
Article on Page 237. Troglitazone entered the U.S. market in 1997 as the first
May 3, 2000 ... The FDA wishes to inform physicians of the removal from the market of
troglitazone (Rezulin, Parke-Davis/Warner-Lambert Co, Morris Plains, ...
Structure, properties, spectra, suppliers and links for: Troglitazone.